This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.
Company Profile:
Gain Therapeutics, Inc.
Market Cap (USD):
$50.6 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Adicet Bio, Inc.
Market Cap (USD):
$50.2 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
AlloVir, Inc.
Market Cap (USD):
$49.5 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Starpharma Holdings Limited
Market Cap (USD):
$49.1 M
(Jan. 1, 2024)
Country:
Australia
Sector:
Australian Healthcare
Industry:
Australian Biotechnology
Company Profile:
Orthocell Limited
Market Cap (USD):
$48.8 M
(July 1, 2024)
Country:
Australia
Sector:
Australian Healthcare
Industry:
Australian Biotechnology
Company Profile:
Inovio Pharmaceuticals, Inc.
Market Cap (USD):
$48.8 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Aeglea BioTherapeutics, Inc.
Market Cap (USD):
$48.6 M
(Jan. 1, 2024)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Werewolf Therapeutics, Inc.
Market Cap (USD):
$48.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Aligos Therapeutics, Inc.
Market Cap (USD):
$47.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Adverum Biotechnologies, Inc.
Market Cap (USD):
$47.6 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
I-Tech AB
Market Cap (USD):
$46.9 M
(July 1, 2024)
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Biotechnology
Company Profile:
Annovis Bio, Inc.
Market Cap (USD):
$46.0 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Zivo Bioscience, Inc.
Market Cap (USD):
$45.7 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Aileron Therapeutics, Inc.
Market Cap (USD):
$45.7 M
(March 1, 2025)
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Delta-Fly Pharma, Inc.
Market Cap (USD):
$45.4 M
Country:
Japan
Sector:
Japanese Healthcare
Industry:
Japanese Biotechnology
Company Profile:
Applied Therapeutics, Inc.
Market Cap (USD):
$45.3 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Vivoryon Therapeutics N.V.
Market Cap (USD):
$45.1 M
Country:
Germany
Sector:
German Healthcare
Industry:
German Biotechnology
Company Profile:
Actinium Pharmaceuticals, Inc.
Market Cap (USD):
$44.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Prelude Therapeutics Incorporated
Market Cap (USD):
$44.8 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Mabion SA
Market Cap (USD):
$44.5 M
Country:
Poland
Sector:
Polish Healthcare
Industry:
Polish Biotechnology
Company Profile:
MedMira, Inc.
Market Cap (USD):
$43.9 M
Country:
Canada
Sector:
Canadian Healthcare
Industry:
Canadian Biotechnology
Company Profile:
Carna Biosciences, Inc.
Market Cap (USD):
$43.3 M
Country:
Japan
Sector:
Japanese Healthcare
Industry:
Japanese Biotechnology
Company Profile:
Malin Corp plc
Market Cap (USD):
$42.4 M
Country:
Ireland
Sector:
Irish Healthcare
Industry:
Irish Biotechnology
Company Profile:
BerGenBio ASA
Market Cap (USD):
$42.0 M
(July 1, 2024)
Country:
Norway
Sector:
Norway Healthcare
Industry:
Norway Biotechnology
Company Profile:
Shattuck Labs, Inc.
Market Cap (USD):
$39.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
GeneReach Biotechnology Corp
Market Cap (USD):
$39.7 M
Country:
Taiwan
Sector:
Taiwanese Healthcare
Industry:
Taiwanese Biotechnology
Company Profile:
Auris Medical Holding Ltd.
Market Cap (USD):
$39.2 M
(June 1, 2022)
Country:
Bermuda
Sector:
Bermuda Healthcare
Industry:
Bermuda Biotechnology
Company Profile:
Iterum Therapeutics plc
Market Cap (USD):
$38.6 M
Country:
Ireland
Sector:
Irish Healthcare
Industry:
Irish Biotechnology
Company Profile:
Karyopharm Therapeutics Inc.
Market Cap (USD):
$37.9 M
Country:
United States
Sector:
US Healthcare
Industry:
US Biotechnology
Company Profile:
Akari Therapeutics, Plc
Market Cap (USD):
$37.6 M
Country:
United Kingdom
Sector:
UK Healthcare
Industry:
UK Biotechnology